West Pharmaceutical Services Inc. logo

West Pharmaceutical Services Inc. (WPS)

Market Closed
26 Jun, 07:31
186. 75
-3.4
-1.79%
- Market Cap
49.01 P/E Ratio
0.8% Div Yield
0 Volume
7.62 Eps
190.15
Previous Close
Day Range
186.75 186.9
Year Range
166.95 333.3
Want to track WPS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 25 days

Summary

WPS closed Thursday lower at €186.75, a decrease of 1.79% from Wednesday's close, completing a monthly decrease of -0.11% or €0.2. Over the past 12 months, WPS stock lost -40.54%.
WPS pays dividends to its shareholders, with the most recent payment made on May 07, 2025. The next announced payment will be in In 1 month on Aug 06, 2025 for a total of €0.21.
The last earnings report, released on Apr 23, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.15%, based on the last three reports. The next scheduled earnings report is due on Jul 23, 2025.
West Pharmaceutical Services Inc. has completed 4 stock splits, with the recent split occurring on Sep 27, 2013.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NYSE (USD).

WPS Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
Investors in West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights – WST

Investors in West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights – WST

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit.

Globenewswire | 12 hours ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Prnewswire | 18 hours ago
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders

NEW YORK , June 27, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025.

Prnewswire | 19 hours ago

West Pharmaceutical Services Inc. Dividends

West Pharmaceutical Services Inc. logo
WST In 1 month
Announced
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 1 month ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 4 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 7 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 10 months ago
Paid
Quarterly
$0.2 Per Share

West Pharmaceutical Services Inc. Earnings

23 Jul 2025 (In 3 weeks) Date
-
Cons. EPS
-
EPS
23 Apr 2025 Date
-
Cons. EPS
-
EPS
13 Feb 2025 Date
1.71
Cons. EPS
1.82
EPS
24 Oct 2024 Date
1.5
Cons. EPS
1.85
EPS
25 Jul 2024 Date
1.74
Cons. EPS
1.52
EPS
West Pharmaceutical Services Inc. logo
WST In 1 month
Announced
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 1 month ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 4 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 7 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 10 months ago
Paid
Quarterly
$0.2 Per Share
23 Jul 2025 (In 3 weeks) Date
-
Cons. EPS
-
EPS
23 Apr 2025 Date
-
Cons. EPS
-
EPS
13 Feb 2025 Date
1.71
Cons. EPS
1.82
EPS
24 Oct 2024 Date
1.5
Cons. EPS
1.85
EPS
25 Jul 2024 Date
1.74
Cons. EPS
1.52
EPS

West Pharmaceutical Services Inc. (WPS) FAQ

What is the stock price today?

The current price is €186.75.

On which exchange is it traded?

West Pharmaceutical Services Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is WPS.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.8%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Jul 23, 2025.

Has West Pharmaceutical Services Inc. ever had a stock split?

West Pharmaceutical Services Inc. had 4 splits and the recent split was on Sep 27, 2013.

West Pharmaceutical Services Inc. Profile

Medical - Instruments & Supplies Industry
Healthcare Sector
Mr. Eric M. Green CEO
XDUS Exchange
US9553061055 ISIN
US Country
10,600 Employees
30 Apr 2025 Last Dividend
27 Sep 2013 Last Split
13 Jan 1978 IPO Date
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Contact Information

Address: 530 Herman O. West Drive
Phone: 610 594 2900